• Home
  • Politics
  • Health
  • World
  • Business
  • Finance
  • Tech
  • More
    • Sports
    • Entertainment
    • Lifestyle
What's Hot

How Smart Mattresses Improve Sleep Quality For Couples

May 9, 2025

OpenAI CEO Warns: ‘Not A Huge Amount Of Time’ Until China Overpowers American AI

May 9, 2025

Short and Funny Sayings for a Happy Summer with Friends

May 9, 2025
Facebook Twitter Instagram
  • Contact
  • Privacy Policy
  • Terms & Conditions
Friday, May 9
Patriot Now NewsPatriot Now News
  • Home
  • Politics

    Security video shows brazen sexual assault of California woman by homeless man

    October 24, 2023

    Woman makes disturbing discovery after her boyfriend chases away home intruder who stabbed him

    October 24, 2023

    Poll finds Americans overwhelmingly support Israel’s war on Hamas, but younger Americans defend Hamas

    October 24, 2023

    Off-duty pilot charged with 83 counts of attempted murder after allegedly trying to shut off engines midflight on Alaska Airlines

    October 23, 2023

    Leaked audio of Shelia Jackson Lee abusively cursing staffer

    October 22, 2023
  • Health

    Disparities In Cataract Care Are A Sorry Sight

    October 16, 2023

    Vaccine Stocks—Including Pfizer, Moderna, BioNTech And Novavax—Slide Amid Plummeting Demand

    October 16, 2023

    Long-term steroid use should be a last resort

    October 16, 2023

    Rite Aid Files For Bankruptcy With More ‘Underperforming Stores’ To Close

    October 16, 2023

    Who’s Still Dying From Complications Related To Covid-19?

    October 16, 2023
  • World

    New York Democrat Dan Goldman Accuses ‘Conservatives in the South’ of Holding Rallies with ‘Swastikas’

    October 13, 2023

    IDF Ret. Major General Describes Rushing to Save Son, Granddaughter During Hamas Invasion

    October 13, 2023

    Black Lives Matter Group Deletes Tweet Showing Support for Hamas 

    October 13, 2023

    AOC Denounces NYC Rally Cheering Hamas Terrorism: ‘Unacceptable’

    October 13, 2023

    L.A. Prosecutors Call Out Soros-Backed Gascón for Silence on Israel

    October 13, 2023
  • Business

    OpenAI CEO Warns: ‘Not A Huge Amount Of Time’ Until China Overpowers American AI

    May 9, 2025

    Trump Announces First Post-Tariff Trade Deal

    May 8, 2025

    Electric Vehicle Sales Nosedive As GOP Takes Buzzsaw To Biden’s Mandate

    May 7, 2025

    Tyson Foods Announces It Will Bend The Knee To Trump Admin’s New Rules

    May 7, 2025

    Federal Reserve Holds Interest Rates Steady Despite Pressure From Trump

    May 7, 2025
  • Finance

    Ending China’s De Minimis Exception Brings 3 Benefits for Americans

    April 17, 2025

    The Trump Tariff Shock Should Push Indonesia to Reform Its Economy

    April 17, 2025

    Tariff Talks an Opportunity to Reinvigorate the Japan-US Alliance

    April 17, 2025

    How China’s Companies Are Responding to the US Trade War

    April 16, 2025

    The US Flip-flop Over H20 Chip Restrictions 

    April 16, 2025
  • Tech

    Cruz Confronts Zuckerberg on Pointless Warning for Child Porn Searches

    February 2, 2024

    FTX Abandons Plans to Relaunch Crypto Exchange, Commits to Full Repayment of Customers and Creditors

    February 2, 2024

    Elon Musk Proposes Tesla Reincorporates in Texas After Delaware Judge Voids Pay Package

    February 2, 2024

    Tesla’s Elon Musk Tops Disney’s Bob Iger as Most Overrated Chief Executive

    February 2, 2024

    Mark Zuckerberg’s Wealth Grew $84 Billion in 2023 as Pedophiles Target Children on Facebook, Instagram

    February 2, 2024
  • More
    • Sports
    • Entertainment
    • Lifestyle
Patriot Now NewsPatriot Now News
Home»Health»First new TB shot since the BCG vaccine enters trial phase
Health

First new TB shot since the BCG vaccine enters trial phase

June 28, 2023No Comments5 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
First new TB shot since the BCG vaccine enters trial phase
Share
Facebook Twitter LinkedIn Pinterest Email

The Gates Foundation said Wednesday it plans to launch a long-awaited trial to test what, if proven effective, would be the first new tuberculosis vaccine in over a century.

The 26,000-person, Phase 3 study will test a vaccine known as M72/AS01 that showed promising results from a smaller trial in 2019. The findings stoked excitement at the time. But a larger, confirmatory study was delayed as GSK, the company then developing it, transferred the shot to the Gates Foundation rather than move forward with the vaccine itself.

“We experienced quite a bit of frustration with how long it took,” said Thomas Scriba, a University of Cape Town immunologist and an investigator on the both studies, calling the news “an unbelievably positive development … the world really needs a TB vaccine.”

To be clear, there has been a tuberculosis vaccine since 1921, when a French team created what’s known as the BCG vaccine from the bacteria that causes bovine tuberculosis. It is given to children in many middle- and low-income countries, but studies measuring its effectiveness have shown mixed results, and it doesn’t protect adolescents or adults.

Meanwhile, tuberculosis remains a leading global cause of death, claiming about 1.6 million lives every year, more than any other infectious disease before Covid’s emergence.

No new shots have been developed since the BCG vaccine, in part because of scientific hurdles — tuberculosis is a far more complex pathogen than, say, SARS-CoV-2 — and in part because the disease primarily affects the planet’s poorest, providing little financial incentive for pharma companies.

Nomathamsanqa Majozi, head of public engagement at the Africa Health Research Institute, described on a foundation press call the toll that tuberculosis continues to take in her home of KwaZulu Natal, South Africa. More than half of the community has or will develop tuberculosis. Many are wage laborers, so falling sick can not only endanger their lives, but also their families’ economic stability.

See also  Complex Plot Outlined In Murder Trial Of Idaho 'Doomsday Mom'

There are “catastrophic costs,” she said.

The Gates Foundation, which also funded early research on the shot, plans to start the trial in 2024. It has committed $400 million to the trial, and the U.K.’s Wellcome Trust is committing up to an additional $150 million. The trial will take place across more than 50 sites in Africa and Asia and likely take four to six years to complete, Trevor Mundel, the Gates Foundation president of global health, told reporters.

It will take time to both recruit people and for enough people in the study to get sick so that researchers can see whether the shot is working. Mundel said they will analyze the shot’s efficacy once 150 people across the vaccine and placebo arm develop active disease.

The study won’t primarily test whether the vaccine can protect children who have never been exposed to TB, as the BCG shot is supposed to. Rather, the trial will see if it can prevent adults and adolescents with latent tuberculosis infection — that is, people who are infected but have no symptoms — from developing full-blown illness.

Recent estimates suggest about a quarter of the global population has latent tuberculosis infection. About 5%-15% will develop the disease during their lifetime. The 2019 study results indicated that the M72 vaccine cut the risk of developing full-blown tuberculosis by 49.7%.

“It’s really a big deal,” said Maziar Divangahi, associate director of the McGill International TB Centre. “If this vaccine could reduce the disease by 50%, that has tremendous implications worldwide.”

See also  Sports medicine is finally prioritizing gender equality

Such a reduction, he said, could significantly curb tuberculosis transmission, as people with latent infection can’t spread the bacteria. A 2022 WHO report estimated that a 50% effective TB vaccine for adults and adolescents could prevent 37.2 million to 76 million cases and 4.6-8.5 million deaths by 2050.

Divangahi cautioned, however, against putting too much faith in the 2019 results. In that trial, 39 people — 26 in the placebo group, and 13 in the vaccine group — became sick, so the sample size was “extremely low,” he said. And no one knows how long protection might last.

Although the Gates Foundation is manufacturing the vaccine, GSK will continue supplying an adjuvant, a molecule designed to amplify the vaccines’ signal to the immune system. A GSK spokesperson said that given the complexity of running a Phase 3 trial in lower-income countries, the company believed the Gates Foundation was the best organization to move forward with the vaccine, and that GSK’s “most important contribution to global health is the science, investigating proof-of-concept through phase 2.”

If the vaccine succeeds, the Gates Foundation’s work will be far from over. Mundel said the foundation would need to find a partner to manufacture the drug for a commercial market. And given that tuberculosis primarily affects the poorest groups in low-income countries, experts warn rollout will be daunting.

Although latent tuberculosis can already be treated with antibiotics, those drugs require people to take pills for at least a month. Many low-income countries don’t have the extensive resources required to identify and dose infected individuals.

A two-dose shot should be more scalable, said Mel Spigelman, CEO of TB Alliance, but it “will still be a very expensive and daunting task” to find and dose potentially billions of people.

See also  Why do we get seasonal allergies?

“That will require a lot of resources,” he said, “that aren’t presently being devoted to TB.”

BCG Enters Phase shot trial vaccine
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Posts

The Next Phase of the China-US Trade War Has Begun

February 4, 2025

Thailand to Begin Phase 2 of ‘Digital Wallet’ Stimulus in January

November 20, 2024

Disney Agrees To Wrongful Death Trial After Facing Blowback For Trying To Dodge Case

August 20, 2024

Vietnam Opens Trial in $12.5 Billion Corruption Case

March 6, 2024
Add A Comment

Leave A Reply Cancel Reply

Top Posts

Zombie Network: CNN Has Disastrous Month Of March – Primetime Ratings Down 61%

April 1, 2023

Sugar-sweetened beverages linked with increased risk of premature death for people with type 2 diabetes

April 20, 2023

Ocasio-Cortez is upset at parody account ‘going viral’ and ‘gaining speed’ after being boosted by Elon Musk

May 31, 2023

Most Americans Cutting Back on Amusement Parks, Live Entertainment as Prices Soar Under Biden

October 22, 2023
Don't Miss

How Smart Mattresses Improve Sleep Quality For Couples

Lifestyle May 9, 2025

Sharing a bed with your partner can be romantic… until it’s not. One of you…

OpenAI CEO Warns: ‘Not A Huge Amount Of Time’ Until China Overpowers American AI

May 9, 2025

Short and Funny Sayings for a Happy Summer with Friends

May 9, 2025

Trump Announces First Post-Tariff Trade Deal

May 8, 2025
About
About

This is your World, Tech, Health, Entertainment and Sports website. We provide the latest breaking news straight from the News industry.

We're social. Connect with us:

Facebook Twitter Instagram Pinterest
Categories
  • Business (4,111)
  • Entertainment (4,220)
  • Finance (3,202)
  • Health (1,938)
  • Lifestyle (1,628)
  • Politics (3,084)
  • Sports (4,036)
  • Tech (2,006)
  • Uncategorized (4)
  • World (3,944)
Our Picks

Russian Diplomat with ‘Penchant for Loungewear’ Squatting on Canceled Embassy Site

June 26, 2023

105 Regret Quotes to Help You Let Go and Move on With Your Life

February 19, 2023

Don’t Swallow Boric Acid Vaginal Suppositories, What A TikToker Did

May 27, 2023
Popular Posts

How Smart Mattresses Improve Sleep Quality For Couples

May 9, 2025

OpenAI CEO Warns: ‘Not A Huge Amount Of Time’ Until China Overpowers American AI

May 9, 2025

Short and Funny Sayings for a Happy Summer with Friends

May 9, 2025
© 2025 Patriotnownews.com - All rights reserved.
  • Contact
  • Privacy Policy
  • Terms & Conditions

Type above and press Enter to search. Press Esc to cancel.